Standard Biotools LAB
NASDAQ LAB
$0.71 +0.06 (+9.23%)
At close: Nov 13, 2026 · 4:00 PM EST

Standard Biotools (LAB) Cash from Discontinued Operations (2025 - 2026)

Updated

Standard Biotools (LAB) reported Cash from Discontinued Operations of -$28.46 million for Q3 2026, compared with $3 million a year earlier.

Analysis

Standard Biotools (LAB) Cash from Discontinued Operations (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Standard Biotools' Cash from Discontinued Operations came in at -$161.92 million.

  • Five-year quarterly Cash from Discontinued Operations spans a low of -$141.69 million in Q1 2026 and a high of $15.79 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discont. Ops (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn -
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn -
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -28.00 Mn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn -
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn -
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 1.46 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn -
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn -
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn -
10 Standard Biotools 280.22 Mn -1.30 Bn 10.83 Mn -28.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -28.46 Mn
Jun 30, 2026 5.23 Mn
Mar 31, 2026 -141.69 Mn
Sep 30, 2025 3.00 Mn
Jun 30, 2025 15.79 Mn
Mar 31, 2025 2.66 Mn
API Access

Standard Biotools Cash from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-discontinued-operations&ticker=LAB&period=max&api_key=YOUR_API_KEY